INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 47m ago
HOUSE PTR7m ago
SEC 13F7m ago
ROBINHOOD CHAIN7m ago
Corporate insider
ML

Muller Lorenz

Chief Commercial OfficerCIK 0001771207

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 2
Max Insider Score62
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
36
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$22K
11.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Milestone Pharmaceuticals Inc.Chief Commercial Officer · Dec 11, 2025
9
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Option exercise
M
—
20.1K sh
Jan 26, 2026
Jan 28, 2026
traded Jan 26, 2026
+2d
SEC FORM 4

Evidence

62
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$124K
53.6K sh
Dec 15, 2025Jan 28, 2026
traded Dec 15, 2025
+44dSEC FORM 4

Evidence

36
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Grant or award
A—
100.0K sh
Dec 12, 2025Jan 28, 2026
traded Dec 12, 2025
+47dSEC FORM 4

Evidence

24
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Grant or award
A—
100.0K sh
Dec 12, 2025Jan 28, 2026
traded Dec 12, 2025
+47dSEC FORM 4

Evidence

17
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Option exercise
M—
20.1K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

16
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Gift
G—
25.0K sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC FORM 4

Evidence